SAPL financials Sanofi-Aventis Pakistan Limited
Sanofi-Aventis Pakistan Limited (SAPL) has 13 financial years on file, from the year to 31 Dec 2010. The latest, the year to 31 Dec 2022 brought revenue of Rs 18.6 bn.
Annual report figures: income and balance sheet
From each annual report. A blank is a line this page does not show for that year.
| Year | Revenue | Gross profit | Profit after tax | Total assets | Equity | Liabilities | Return on equity | Current ratio | Basis |
|---|---|---|---|---|---|---|---|---|---|
| Year to 31 Dec 2022 | Rs 18.6 bn | Rs 4.9 bn | Rs 167.0 m | Rs 12.3 bn | Rs 5.1 bn | — | 3.3% | 1.41 | unknown |
| Year to 31 Dec 2021 | Rs 15.9 bn | Rs 4.1 bn | Rs 906.0 m | Rs 9.3 bn | Rs 5.2 bn | — | 17.4% | — | unknown |
| Year to 31 Dec 2020 | Rs 14.1 bn | Rs 3.8 bn | Rs 493.0 m | Rs 8.7 bn | Rs 4.7 bn | — | 10.5% | 1.74 | unknown |
| Year to 31 Dec 2019 | Rs 14.5 bn | Rs 3.7 bn | Rs 155.0 m | Rs 7.7 bn | Rs 3.9 bn | — | 4.0% | 1.64 | unknown |
| Year to 31 Dec 2018 | Rs 13.0 bn | Rs 3.9 bn | Rs 613.0 m | Rs 7.8 bn | — | — | — | 1.73 | unknown |
| Year to 31 Dec 2017 | Rs 12.4 bn | Rs 4.4 bn | Rs 1.0 bn | Rs 6.6 bn | Rs 4.1 bn | — | 24.3% | 1.98 | unknown |
| Year to 31 Dec 2016 | Rs 11.9 bn | Rs 4.0 bn | Rs 1.0 bn | Rs 6.8 bn | Rs 3.4 bn | — | 29.9% | 1.73 | unknown |
| Year to 31 Dec 2015 | Rs 10.8 bn | Rs 2.8 bn | Rs -72.4 m | Rs 7.4 bn | Rs 2.4 bn | — | -3.0% | 1.22 | unknown |
| Year to 31 Dec 2014 | Rs 9.9 bn | Rs 2.5 bn | Rs -22.9 m | Rs 7.8 bn | Rs 2.4 bn | — | -1.0% | 1.21 | unknown |
| Year to 31 Dec 2013 | Rs 8.8 bn | Rs 2.7 bn | Rs -36.3 m | Rs 6.5 bn | Rs 2.2 bn | — | -1.6% | 1.27 | unknown |
| Year to 31 Dec 2012 | Rs 8.6 bn | Rs 2.6 bn | Rs 111.7 m | Rs 5.5 bn | Rs 2.0 bn | — | 5.5% | 1.16 | unknown |
| Year to 31 Dec 2011 | Rs 7.6 bn | Rs 2.0 bn | Rs 2.7 m | Rs 4.4 bn | Rs 1.6 bn | — | 0.2% | 1.12 | unknown |
| Year to 31 Dec 2010 | Rs 6.2 bn | Rs 1.8 bn | Rs 34.1 m | Rs 3.3 bn | Rs 1.5 bn | — | 2.3% | 1.41 | unknown |
Source: annual report, page 112.
Ratios from the latest annual report
- Return on equity
- 3.3%
- Return on assets
- 1.4%
- Book value a share
- Rs 523.72
- Price to book value
- 1.66 times
- Current ratio
- 1.41
- Debt to equity
- 1.44
- Equity as a share of assets
- 41.0%
- Gross margin
- 26.2%
- Operating margin
- 4.2%
- Tax rate paid
- 76.9%
As of 31 Dec 2022.
More on SAPL
- SAPL share price and overview
- Pharmaceuticals sector
- SEARL financials · The Searle Company Limited
- ABOT financials · Abbott Laboratories (Pakistan) Limited
- GLAXO financials · GlaxoSmithKline Pakistan Limited
- HALEON financials · Haleon Pakistan Limited
- HINOON financials · Highnoon Laboratories Limited
Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .